|
VRK3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.685580E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.045200E-01 |
| Normal-vs-Stage2 |
2.487200E-01 |
| Normal-vs-Stage3 |
1.276340E-03 |
| Normal-vs-Stage4 |
6.337000E-03 |
| Stage1-vs-Stage2 |
3.468600E-01 |
| Stage1-vs-Stage3 |
2.542700E-03 |
| Stage1-vs-Stage4 |
8.584000E-03 |
| Stage2-vs-Stage3 |
2.337800E-01 |
| Stage2-vs-Stage4 |
2.715000E-01 |
| Stage3-vs-Stage4 |
9.965200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.025800E-02 |
| Normal-vs-AfricanAmerican |
8.379900E-03 |
| Normal-vs-Asian |
9.157200E-01 |
| Caucasian-vs-AfricanAmerican |
1.492230E-01 |
| Caucasian-vs-Asian |
2.259400E-01 |
| AfricanAmerican-vs-Asian |
4.235800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.163300E-04 |
| Normal-vs-Female |
5.895400E-01 |
| Male-vs-Female |
1.155850E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.579770E-02 |
| Normal-vs-Age(41-60Yrs) |
9.612000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.718200E-02 |
| Normal-vs-Age(81-100Yrs) |
8.885400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.447600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.028210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.700400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.315200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.108000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.217600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.250300E-02 |
| Normal-vs-Grade 2 |
4.301200E-01 |
| Normal-vs-Grade 3 |
4.206400E-02 |
| Normal-vs-Grade 4 |
1.0697000000226E-06 |
| Grade 1-vs-Grade 2 |
4.447800E-02 |
| Grade 1-vs-Grade 3 |
2.220200E-02 |
| Grade 1-vs-Grade 4 |
6.32560000000115E-05 |
| Grade 2-vs-Grade 3 |
2.075600E-01 |
| Grade 2-vs-Grade 4 |
8.27090000000696E-05 |
| Grade 3-vs-Grade 4 |
2.439700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.353950E-02 |
| Normal-vs-ccB subtype |
3.27050053705591E-10 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.576200E-01 |
| Normal-vs-N1 |
3.129500E-02 |
| N0-vs-N1 |
6.672400E-02 |
|
|
